Treatment with once-daily exenatide plus dapagliflozin and without rescue therapy was associated with clinically relevant changes in fasting plasma glucose.
The effects of the COVID-19 pandemic on the diagnosis and presentation of pediatric type 1 diabetes.
Children who received a new diagnosis of type 1 diabetes during the COVID-19 pandemic are presenting with higher rates of diabetic ketoacidosis than in the previous 2 years.
This study found that diabetic patients with COVID-19 had lower lymphocyte counts and hospital stays.
The treatment of patients with familial hypercholesterolemia and COVID-19 with dyslipidemia medications may prevent the occurrence of thrombotic events.
Several questions remain regarding the effect of COVID-19 infection and hypercoagulation in the management of patients taking oral contraceptives, estrogen therapy, and patients who are pregnant.
Suboptimal adherence to and low prescribing of high-intensity statin therapy may be associated with the modest reductions in LDL-C observed in patients with ASCVD.
Up-titration to high-intensity statins early on in the course of treatment was found to be associated with a lower risk for cardiovascular (CV) events compared with no up-titration in patients at very high risk for CV disease.
Alirocumab was found to be well tolerated and to produce long-term reductions in low-density lipoprotein cholesterol in patients who are intolerant to statins.
Hypertension and dyslipidemia display a correlation with rosacea, although ischemic heart disease, stroke, and diabetes do not.
